Alessandro Orlando

ORCID: 0000-0003-2900-3988 · 2 papers in corpus
2016
rct 2016
Acta ophthalmologica ·doi:10.1111/aos.13318

Although intra-ocular antivascular endothelial growth factor (VEGF) injections are the standard of care for patients with diabetic macular oedema (DME), some fail this treatment. This begets the need for alternative therapies for these pati…